The estimated Net Worth of Julie Krop is at least $670 Thousand dollars as of 28 May 2019. Julie Krop owns over 10,000 units of Aquestive Therapeutics Inc stock worth over $402,925 and over the last 9 years Julie sold AQST stock worth over $267,457.
Julie has made over 4 trades of the Aquestive Therapeutics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Julie bought 10,000 units of AQST stock worth $99,100 on 28 May 2019.
The largest trade Julie's ever made was buying 10,000 units of Aquestive Therapeutics Inc stock on 28 May 2019 worth over $99,100. On average, Julie trades about 989 units every 43 days since 2015. As of 28 May 2019 Julie still owns at least 81,399 units of Aquestive Therapeutics Inc stock.
You can see the complete history of Julie Krop stock trades at the bottom of the page.
Julie's mailing address filed with the SEC is C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN, NJ, 07059.
Over the last 6 years, insiders at Aquestive Therapeutics Inc have traded over $1,898,648 worth of Aquestive Therapeutics Inc stock and bought 370,463 units worth $3,088,399 . The most active insiders traders include Marco Taglietti, Nancy Lurker, and Alexander Mark Schobel. On average, Aquestive Therapeutics Inc executives and independent directors trade stock every 36 days with the average trade being worth of $77,928. The most recent stock trade was executed by Alexander Mark Schobel on 15 March 2024, trading 50,000 units of AQST stock currently worth $300,000.
aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people’s lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.
Aquestive Therapeutics Inc executives and other stock owners filed with the SEC include: